Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
over-the-counter medication
|
| gptkbp:activeIngredient |
gptkb:aspirin
caffeine acetaminophen |
| gptkbp:availableOn |
gptkb:tablet
caplet |
| gptkbp:brand |
acetaminophen, aspirin, and caffeine combination
|
| gptkbp:contains |
250 mg acetaminophen
250 mg aspirin 65 mg caffeine |
| gptkbp:contraindication |
children with viral infections
allergy to NSAIDs bleeding disorders |
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:United_States |
| gptkbp:FDAApproved |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Excedrin Extra Strength
|
| gptkbp:introducedIn |
1960
|
| gptkbp:legalStatus |
OTC (over-the-counter)
|
| gptkbp:manufacturer |
gptkb:Novartis
GlaxoSmithKline |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
insomnia stomach upset |
| gptkbp:usedFor |
headache
pain relief migraine |
| gptkbp:website |
https://www.excedrin.com/
|
| gptkbp:bfsParent |
gptkb:Excedrin
|
| gptkbp:bfsLayer |
6
|